Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.
Also called NCT03945305
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT03945305
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT03945305. Randomized; single masking; primary purpose treatment. Start 2023-11-25 (actual); primary completion 2026-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension
- Condition
- Essential Hypertension
- Intervention (Device)
- Patients are treated with previous antihypertensive treatment plus remote ischemic conditioning.
- Intervention (Other)
- Previous antihypertensive treatment
- Lead sponsor
- Yi Yang
Record details
- Record id
cardio:ct-nct03945305- Content hash
684bf73977d2b39ad9b0ee83c54cbf34a5f81d62172f2d32526326ff62d10bcd